Brontictuzumab (

INN Inns are generally establishments or buildings where travelers can seek lodging, and usually, food and drink. Inns are typically located in the country or along a highway; before the advent of motorized transportation they also provided accommo ...

; development code OMP-52M51) is a humanized monoclonal antibody designed for the treatment of cancer. This drug was developed by

OncoMed Pharmaceuticals OncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in Redwood City, California. The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha. ...

References

{{monoclonal-antibody-stub Monoclonal antibodies